LENZ Therapeutics, Inc. Share Price OTC Markets
Equities
GRPH
US52635N1037
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 20.46M 1.71B | Capitalization | 413M 34.47B |
---|---|---|---|---|---|
Net income 2024 * | -55M -4.59B | Net income 2025 * | -70M -5.84B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 20.2 x |
P/E ratio 2024 * |
-7.4
x | P/E ratio 2025 * |
-6.65
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.31% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.45% | - |
1st Jan change | Capi. | |
---|---|---|
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |